ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
1,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
2,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2,2,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
3,1,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
4,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
5,1,Epididymitis,Male reproductive tract infections,Infections - pathogen unspecified,Infec,N
5,2,Prostatitis,Prostate and seminal vesicles infections and inflammations,Male reproductive tract infections and inflammations,Repro,N
6,1,Thrombophlebitis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
7,1,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
8,1,Osteomyelitis,Bone and joint infections,Infections - pathogen unspecified,Infec,N
9,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
9,2,Premature delivery,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
10,1,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
11,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
11,2,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
12,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
12,2,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
13,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
14,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
14,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
15,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
16,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
17,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
18,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
19,1,Eosinophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
19,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
20,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
20,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
20,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
20,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
20,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
20,6,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
20,7,Retching,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
21,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
21,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
21,3,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
21,4,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
21,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
21,6,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
21,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
22,1,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
23,1,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
23,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
23,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
23,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
24,1,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
24,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
24,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
24,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
25,1,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
25,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
26,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
27,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
27,2,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
28,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
29,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
29,2,Cystic fibrosis,Pulmonary and bronchial disorders congenital,Respiratory disorders congenital,Cong,N
29,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
30,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
30,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
30,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
30,4,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
31,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
31,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
31,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
31,4,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
